Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031
The global market for ophthalmic drugs is increasing yearly. Your competitors in the ophthalmic drugs market are benefiting from key...Full DetailsPUBLISHED: 04 March 2021Rare Diseases Market Report 2021-2031
Increasing cases of rare genetic diseases coupled with rising number of US FDA approvals for treatment of rare diseases is...Full DetailsPUBLISHED: 01 March 2021Non-alcoholic Fatty Liver Disease (NAFLD) & NASH Market Report 2021-2031
The report study aims to explore the market drivers, restraints and also market opportunities facing non-alcoholic fatty liver disease &...Full DetailsPUBLISHED: 17 February 2021Mental Disorder Drugs Market Report 2021-2031
Rising prevalence of mental disorders; mounting investment in drug R&D by pharmaceutical & biopharmaceutical companies; growing mental health care awareness;...Full DetailsPUBLISHED: 12 February 2021Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2021-2031
Rising investment in drug R&D by pharmaceutical and biopharmaceutical companies, increasing prevalence of retinal diseases, mounting demand for biologics &...Full DetailsPUBLISHED: 11 February 2021Cancer Biologics Market Report 2021-2031
The global demand for cancer biologics is expected to expand significantly over the projected period, owing to the expanded acceptance...Full DetailsPUBLISHED: 04 February 2021Vaccine Adjuvants Market Report 2021-2031
The opportunity for innovation within the vaccine adjuvants market remains strong. As time progresses, the technology used in the manufacturing...Full DetailsPUBLISHED: 02 February 2021CNS Therapeutics Market Report 2021-2031
Due to the rapid transmittal of the disease, there has been a sharp increase in number of cases worldwide. While...Full DetailsPUBLISHED: 25 January 2021Veterinary Therapeutics Market Report 2021-2031
Where the Veterinary Therapeutics is market heading? If you are involved in this sector you must read this newly updated...Unfractionated Heparin Market Report 2021-2031
Where the Unfractionated Heparin is market heading? If you are involved in this sector you must read this newly updated...
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Single-Cell Analysis Market Report 2022-2032
The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.
26 May 2022
Visiongain Publishes Ophthalmic Devices Market Report 2022-2032
The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.
19 April 2022
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet
13 April 2022
Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.
13 April 2022
